Estrogenicity of essential oils is not required to relieve symptoms of urogenital atrophy in breast cancer survivors.

Bruno M SimõesBertram KohlerRobert B ClarkeJacqui StringerLily Novak-FrazerKeely YoungRiina Rautemaa-RichardsonGiorgia ZucchiniAnne ArmstrongSacha J Howell

Published in: Therapeutic advances in medical oncology (2018)

Certain essential oils demonstrate profound estrogenicity and caution should be exercised before their use in breast cancer survivors. Our minimally estrogenic pessary will be formally tested in clinical trials.

Keyphrases

clinical trial
preterm birth
intellectual disability
sleep quality
phase ii
open label
autism spectrum disorder
physical activity
estrogen receptor